Blog

Trial Results Are Positive For Two Rare Disease Gene Therapies – Pharmaceutical Processing

Trial Results Are Positive For Two Rare Disease Gene Therapies
Pharmaceutical Processing
To date, 11 patients have been dosed with a single intravenous injection of the ABO-102 gene therapy for systemic delivery of a functional copy of the missing SGSH gene associated with onset and progression of the disease. The SGSH gene provides …
Explore the latest developments in ATMPs at SMi's Cell & Gene Therapy 2018EIN News (press release)



all 2 news articles »

2018-05-22 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.